Eating disorders: a diabetes perspective. Part 1
DOI:
https://doi.org/10.47196/diab.v60i1.1317Keywords:
diabetes, eating disorders, disordered eating, mental health, comprehensive approachAbstract
The COVID-19 pandemic had a considerable impact on mental and physical health, exacerbating eating disorders (EDs), especially in people with diabetes mellitus (DM). DM, in any of its types, presents specific challenges in managing food intake, blood glucose levels, and pharmacological treatment, which can contribute to the development or worsening of maladaptive eating behaviors. In people with type 1 DM, bulimia nervosa, anorexia nervosa, and food avoidance/restriction are the most common eating disorders, while in type 2 DM, binge eating episodes without compensatory behaviors are more prevalent.
With the aim of synthesizing recent evidence on the intersection between DM and EDs, clarifying diagnostic definitions (DSM-5 as the main reference), clinical terminology, and considerations for interdisciplinary assessment and intervention, a focused narrative review of indexed literature and normative documents was conducted. Relevant reviews, guidelines, and original articles on diabetes mellitus (DM) and EDs published in recent years were prioritized.
This article aims to examine the relationship between EDs and DM, highlighting how eating disorders can complicate disease management, increase the risk of complications, and create a vicious cycle of mismanagement. A distinction is proposed between disordered eating behaviors, which are more common but not necessarily clinically significant, and diagnosable EDs that require specialized care. Furthermore, predisposing, precipitating, and maintaining factors that influence the development of these disorders are discussed, along with the importance of early and coordinated intervention that includes both medical treatment for DM and psychological support. Recommended interventions include body image education, cognitive behavioral therapy, and family support, with an interdisciplinary approach to improve well-being and diabetes control in these individuals.
References
I. Hernández-Herrero M, Terradas-Mercader P, Latorre-Martínez E, Feliu-Rovira A, Rodríguez-Zaragoza N, Parada-Ricart E. New diagnoses of type 1 diabetes mellitus in children during the COVID-19 pandemic. Regional multicenter study in Spain. Endocrinol Diabetes Nutr. 2022 Nov;69(9):709-714. Spanish. doi: 10.1016/j.endinu.2021.12.003.
II. Hirschler V, Molinari C, Krochik G, Prieto M, et al. Debuts de diabetes mellitus tipo 1 en niños antes, durante y después de la pandemia de COVID-19. Estudio multicéntrico. Rev Soc Arg Diab 2024;58(1):14-22. doi: 10.47196/diab.v58i1.749.
III. Li R, Shen M, Yang Q, Fairley CK, Chai Z, McIntyre R, et al. Global diabetes prevalence in COVID-19 patients and contribution to COVID-19- related severity and mortality. A systematic review and meta-analysis. Diabetes Care. 2023 Apr 1;46(4):890-897. doi: 10.2337/dc22-1943.
IV. Organización Mundial de la Salud. Salud mental y COVID-19: datos iniciales sobre las repercusiones de la pandemia. 2022. Disponible en: https://iris.who.int/bitstream/handle/10665/354393/WHO-2019-nCoV-Sci-Brief-Mental-health-2022.1-spa.pdf?sequence=1
V. Organización Mundial de la Salud. La pandemia de COVID-19 aumenta en un 25% la prevalencia de la ansiedad y la depresión en todo el mundo. Comunicado de prensa. 2022. Disponible en: https://www.who.int/es/news/item/02-03-2022-covid-19-pandemic-triggers-25-increase-in-prevalence-of-anxiety-and-depression-worldwide.
VI. Minano-Garrido EJ, Catalán-Matamoros D, Gómez-Conesa A. Anorexia nervosa after the COVID-19 pandemic. New challenges for physiotherapy. Fisioterapia. 2023 March-April;45(2):71–3. Spanish. doi: 10.1016/j.ft.2022.12.002.
VII. Devoe D, Han A, Anderson A, Katzman DK, Patten SB, Soumbasis A, Flanagan J, Paslakis G, Vyver E, Marcoux G, Dimitropoulos G. The impact of the COVID-19 pandemic on eating disorders: A systematic review. Int J Eat Disord. 2023 Jan;56(1):5-25. doi: 10.1002/eat.23704.
VIII. Minano-Garrido EJ, Catalán-Matamoros D, Gómez-Conesa A. Anorexia nervosa after the COVID-19 pandemic. New challenges for physiotherapy. Fisioterapia. 2023 March-April;45(2):71–3. Spanish. doi: 10.1016/j.ft.2022.12.002.
IX. Murray-Hurtado M, Rivada AM, Pestano-García S, Ramallo-Fariña S. Influencia de la pandemia por COVID-19 en la incidencia de trastornos de la conducta alimentaria. Anales de Pediatría 2024;101(1):21-28. doi: 10.1016/j.anpedi.2024.04.013.
X. Simmons A, McMahon L, Crosbie V, Carlson L. A multidisciplinary team approach to screening, assessment and early intervention for young people with type 1 diabetes and disordered eating behaviour. Clin Child Psychol Psychiatry. 2021 Jul;26(3):629-642. doi: 10.1177/13591045211013872.
XI. Candler T, Murphy R, Pigott A, Gregory JW. Fifteen-minute consultation. Diabulimia and disordered eating in childhood diabetes. Arch Dis Child Educ Pract Ed. 2018 Jun;103(3):118-123. doi: 10.1136/archdischild-2017-312689.
XII. Nieto-Martínez R, González-Rivas JP, Medina-Inojosa JR, Florez H. Are eating disorders risk factors for type 2 diabetes? A systematic review and meta-analysis. Curr Diab Rep. 2017 Nov 22;17(12):138. doi: 10.1007/s11892-017-0949-1.
XIII. Chevinsky JD, Wadden TA, Chao AM. Binge eating disorder in patients with type 2 diabetes: diagnostic and management challenges. Diabetes Metab Syndr Obes 2020 Apr 14;13:1117-1131. doi: 10.2147/DMSO.S213379.
XIV. Dziewa M, Bańka B, Herbet M, Piątkowska-Chmiel I. Eating disorders and diabetes: facing the dual challenge. Nutrients 2023 Sep 12;15(18):3955. doi: 10.3390/nu15183955.
XV. Neumark-Sztainer D, et al. Striving to prevent obesity and other weight-related problems in adolescent girls: The New Moves approach. En: O'Dea JA, Eriksen M (eds), Childhood Obesity Prevention: International Research, Controversies and Interventions. Oxford, 2010. doi: 10.1093/acprof:oso/9780199572915.003.0024.
XVI. American Psychiatric Association. Manual Diagnóstico y Estadístico de los Trastornos Mentales. 2014, 5º Edición.
XVII. Steiger H, Booij L. Eating disorders, heredity and environmental activation: getting epigenetic concepts into practice. J Clin Med. 2020 May 3;9(5):1332. doi: 10.3390/jcm9051332.
XVIII. Duncan L, Yilmaz Z, Gaspar H, Walters R, Goldstein J, Anttila V, Bulik-Sullivan B, Ripke S; Eating Disorders Working Group of the Psychiatric Genomics Consortium; Thornton L, Hinney A, Daly M, Sullivan PF, Zeggini E, Breen G, Bulik CM. Significant locus and metabolic genetic correlations revealed in genome-wide association study of anorexia nervosa. Am J Psychiatry. 2017 Sep 1;174(9):850-858. doi: 10.1176/appi.ajp.2017.16121402.
XIX. American Diabetes Association Professional Practice Committee; 5. Facilitating behavior change and well-being to improve health outcomes. Standards of Medical Care in Diabetes 2022. Diabetes Care 2022; 45 (Supp1): S60-S82. doi: 10.2337/dc22-S005.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 on behalf of the authors. Reproduction rights: Argentine Diabetes Society

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.













